VTEM Banners
VTEM Banners
VTEM Banners
VTEM Banners

One Student’s Death Was a Belated “Wake-Up Call”

Chicago Public Schools Logo

How Chicago Public Schools Got Emergency Supplies of Epinephrine Into Every One of Its Buildings

By Katy Smyser, Phil Rogers and Rich Moy
Tuesday, March 7th, 2017

For many children, the first time they suffer a severe allergic reaction to a food is when they’re in school. Chicago-area public schools can keep extra supplies of epinephrine auto-injectors on hand for just these types of emergencies, but NBC5 Investigates has discovered that a surprising number do not.

Continue Reading

The Do’s and Don’ts of Preventing Peanut Allergies in Babies

The Do’s and Don’ts of Preventing Peanut Allergies in Babies

Peanuts and Opened Shell

Scientists say early and consistent feeding of peanuts can help prevent peanut allergies in children. A food allergy expert explains what parents should know.

By Rebecca Priest
January 31st, 2017

Food allergies have grown in prevalence and severity, and until recently pediatricians have told parents to keep their babies away from peanuts, shellfish and other common allergenic foods.

Continue Reading

Auvi-Q Offers Possible Alternative to Epi-Pen(TM)

Auvi-Q Offers Possible Alternative to Epi-Pen

Various Epinepherine Injectors

By Kristen Stewart
February 6th, 2017

Anyone with severe allergies knows the importance of having an epinephrine auto-injector (EAI) at the ready. However, with the Epi-PenTM jumping more than $500 in price in the last eight years and until recently no other companies having an epinephrine auto-injector device available, not everyone can afford this potentially life-saving medication. That may be about to change as Kaleo’s Auvi-Q re-enters the U.S. market on February 14th.

Continue Reading

Lawmakers Say Mylan Stonewalling Them

Lawmakers Say Mylan Stonewalling Them

Mylan CEO Heather Bresch with arm raised for 'sworn' testimony
Mylan CEO Heather Bresch

By Robert King
February 2nd, 2017

Two high-ranking members of Congress are clamoring for drug maker Mylan to produce documents about its controversial 400 percent price hike of the EpiPen.

Reps. Jason Chaffetz, R-Utah, and Elijah Cummings, D-Md., sent a letter Friday to Mylan, saying that the company hasn't produced enough documents "despite repeated requests." Chaffetz is chairman and Cummings the top Democrat of the House Oversight and Government Reform Committee, which held a hearing on Mylan last year.

Continue Reading

The information provided on this site is in no way intended to be a substitute for medical advice,
diagnosis, or treatment with a licensed physician.
The Allergy Advocacy Association is a 501(c)(3) non-profit, tax-exempt organization.
Copyright 2017© Allergy Advocacy Association, Inc. All rights reserved.  Terms & Conditions